Cargando…

Mixed depression and suicidality in oncology outpatients

INTRODUCTION: Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility,...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernardi, E., Catinari, A., Ferrara, O. M., Bartolucci, G., Ciliberto, M., Carriero, G., Di Benedetto, L., Marzo, E. M., Donofrio, G., Ruggiero, S., Sani, G., Simonetti, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434419/
http://dx.doi.org/10.1192/j.eurpsy.2023.784
_version_ 1785091883883560960
author Bernardi, E.
Catinari, A.
Ferrara, O. M.
Bartolucci, G.
Ciliberto, M.
Carriero, G.
Di Benedetto, L.
Marzo, E. M.
Donofrio, G.
Ruggiero, S.
Sani, G.
Simonetti, A.
author_facet Bernardi, E.
Catinari, A.
Ferrara, O. M.
Bartolucci, G.
Ciliberto, M.
Carriero, G.
Di Benedetto, L.
Marzo, E. M.
Donofrio, G.
Ruggiero, S.
Sani, G.
Simonetti, A.
author_sort Bernardi, E.
collection PubMed
description INTRODUCTION: Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility, such as oncology patients, represent a pivotal strategy to reduce illness burden and suicidality in these subjects OBJECTIVES: The aim of the present project is to assess the characteristics of MxD in oncology outpatients and to compare them with those of outpatients without oncological comorbidity. METHODS: Forty-two oncology outpatients with MxD (ONC-MxD); 34 oncology outpatients and inhibited depression (ONC-inhib); 187 outpatients with MxD without oncological comorbidity (MxD); 224 outpatients with inhibited depression without oncological comorbidity (Inhib) and 168 healthy controls (HC) have been recruited. Analyses made include comparisons of demographic and clinical variables, depression severity, excitatory symptoms, suicidality and functional impairment. RESULTS: Oncology outpatients with depressive disorder showed greater severity of depressive symptoms and greater functional impairment than those without oncological comorbidity (F=187.08; p<.001; F=54.08; p<.001, respectively). ONC-inhib showed greater inhibition than Inhib (p<.001), whereas no differences in levels of excitatory symptoms are present between MxD e ONC-MxD (p=.159). ONC-DMX have a more recent diagnosis of cancer than ONC-inib (F=13.39, p<.001) and higher rates of suicidal ideation (χ²=11.89; p=.008). CONCLUSIONS: Cancer might worsen depression severity, especially in its inhibitory component. Relationships between onset of cancer, excitatory symptoms and suicidality suggest that the period following the diagnosis of cancer is the one at higher risk for suicide. Strategies aiming to treat excitatory symptoms in such period might help reduce risk of suicide in oncology patients. DISCLOSURE OF INTEREST: None Declared
format Online
Article
Text
id pubmed-10434419
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-104344192023-08-18 Mixed depression and suicidality in oncology outpatients Bernardi, E. Catinari, A. Ferrara, O. M. Bartolucci, G. Ciliberto, M. Carriero, G. Di Benedetto, L. Marzo, E. M. Donofrio, G. Ruggiero, S. Sani, G. Simonetti, A. Eur Psychiatry Abstract INTRODUCTION: Mixed depression (MxD), is a nosologic entity characterized by the presence of excitatory symptoms during a depressive episode. MxD embeds high levels of chronicity, functional impairment and suicidality. The assessment of MxD in a subpopulation that features high levels of fragility, such as oncology patients, represent a pivotal strategy to reduce illness burden and suicidality in these subjects OBJECTIVES: The aim of the present project is to assess the characteristics of MxD in oncology outpatients and to compare them with those of outpatients without oncological comorbidity. METHODS: Forty-two oncology outpatients with MxD (ONC-MxD); 34 oncology outpatients and inhibited depression (ONC-inhib); 187 outpatients with MxD without oncological comorbidity (MxD); 224 outpatients with inhibited depression without oncological comorbidity (Inhib) and 168 healthy controls (HC) have been recruited. Analyses made include comparisons of demographic and clinical variables, depression severity, excitatory symptoms, suicidality and functional impairment. RESULTS: Oncology outpatients with depressive disorder showed greater severity of depressive symptoms and greater functional impairment than those without oncological comorbidity (F=187.08; p<.001; F=54.08; p<.001, respectively). ONC-inhib showed greater inhibition than Inhib (p<.001), whereas no differences in levels of excitatory symptoms are present between MxD e ONC-MxD (p=.159). ONC-DMX have a more recent diagnosis of cancer than ONC-inib (F=13.39, p<.001) and higher rates of suicidal ideation (χ²=11.89; p=.008). CONCLUSIONS: Cancer might worsen depression severity, especially in its inhibitory component. Relationships between onset of cancer, excitatory symptoms and suicidality suggest that the period following the diagnosis of cancer is the one at higher risk for suicide. Strategies aiming to treat excitatory symptoms in such period might help reduce risk of suicide in oncology patients. DISCLOSURE OF INTEREST: None Declared Cambridge University Press 2023-07-19 /pmc/articles/PMC10434419/ http://dx.doi.org/10.1192/j.eurpsy.2023.784 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Bernardi, E.
Catinari, A.
Ferrara, O. M.
Bartolucci, G.
Ciliberto, M.
Carriero, G.
Di Benedetto, L.
Marzo, E. M.
Donofrio, G.
Ruggiero, S.
Sani, G.
Simonetti, A.
Mixed depression and suicidality in oncology outpatients
title Mixed depression and suicidality in oncology outpatients
title_full Mixed depression and suicidality in oncology outpatients
title_fullStr Mixed depression and suicidality in oncology outpatients
title_full_unstemmed Mixed depression and suicidality in oncology outpatients
title_short Mixed depression and suicidality in oncology outpatients
title_sort mixed depression and suicidality in oncology outpatients
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10434419/
http://dx.doi.org/10.1192/j.eurpsy.2023.784
work_keys_str_mv AT bernardie mixeddepressionandsuicidalityinoncologyoutpatients
AT catinaria mixeddepressionandsuicidalityinoncologyoutpatients
AT ferraraom mixeddepressionandsuicidalityinoncologyoutpatients
AT bartoluccig mixeddepressionandsuicidalityinoncologyoutpatients
AT cilibertom mixeddepressionandsuicidalityinoncologyoutpatients
AT carrierog mixeddepressionandsuicidalityinoncologyoutpatients
AT dibenedettol mixeddepressionandsuicidalityinoncologyoutpatients
AT marzoem mixeddepressionandsuicidalityinoncologyoutpatients
AT donofriog mixeddepressionandsuicidalityinoncologyoutpatients
AT ruggieros mixeddepressionandsuicidalityinoncologyoutpatients
AT sanig mixeddepressionandsuicidalityinoncologyoutpatients
AT simonettia mixeddepressionandsuicidalityinoncologyoutpatients